clorgyline has been researched along with Chronic Disease in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karoum, F | 1 |
Potkin, S | 1 |
Chuang, LW | 1 |
Murphy, DL | 1 |
Liebowitz, MR | 1 |
Wyatt, RJ | 1 |
1 other study available for clorgyline and Chronic Disease
Article | Year |
---|---|
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
Topics: Carbidopa; Chronic Disease; Clorgyline; Depressive Disorder; Female; Humans; Male; Pargyline; Phenet | 1984 |